Shanghai No1 Pharmacy Co Ltd (600833) — Strategic Asset Allocation Index
Shanghai No1 Pharmacy Co Ltd (600833) has a Strategic Asset Allocation Index of 17.3% as of June 2023. Strategic assets (PP&E of CN¥174.63 Million plus long-term investments of CN¥-) total CN¥174.63 Million, measured against net assets of CN¥1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai No1 Pharmacy Co Ltd Strategic Asset Allocation Index (2001–2021)
This chart shows how Shanghai No1 Pharmacy Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 17.3%, representing strategic assets of CN¥174.63 Million against net assets of CN¥1.01 Billion CNY. Explore Shanghai No1 Pharmacy Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shanghai No1 Pharmacy Co Ltd (2001–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai No1 Pharmacy Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shanghai No1 Pharmacy Co Ltd (600833) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 21.6% | CN¥167.98 Million | CN¥167.98 Million | CN¥- | CN¥777.92 Million | ▲ +11.9 pp |
| 2020 | 9.7% | CN¥72.47 Million | CN¥72.47 Million | CN¥- | CN¥749.32 Million | ▼ -0.6 pp |
| 2019 | 10.3% | CN¥75.41 Million | CN¥75.41 Million | CN¥- | CN¥732.34 Million | ▼ -30.6 pp |
| 2018 | 40.9% | CN¥273.83 Million | CN¥79.78 Million | CN¥194.05 Million | CN¥669.57 Million | ▼ -13.0 pp |
| 2017 | 53.9% | CN¥384.66 Million | CN¥86.20 Million | CN¥298.46 Million | CN¥714.07 Million | ▼ -7.1 pp |
| 2016 | 61.0% | CN¥448.61 Million | CN¥83.77 Million | CN¥364.84 Million | CN¥736.00 Million | ▼ -10.5 pp |
| 2015 | 71.4% | CN¥559.41 Million | CN¥88.24 Million | CN¥471.16 Million | CN¥783.09 Million | ▲ +57.5 pp |
| 2014 | 13.9% | CN¥90.47 Million | CN¥90.47 Million | CN¥- | CN¥650.97 Million | ▼ -16.0 pp |
| 2013 | 29.9% | CN¥160.40 Million | CN¥160.40 Million | CN¥- | CN¥536.14 Million | ▼ -3.2 pp |
| 2012 | 33.1% | CN¥165.29 Million | CN¥165.29 Million | CN¥- | CN¥499.84 Million | ▲ +4.3 pp |
| 2011 | 28.8% | CN¥123.67 Million | CN¥123.67 Million | CN¥- | CN¥429.41 Million | ▼ -1.4 pp |
| 2010 | 30.2% | CN¥131.64 Million | CN¥131.64 Million | CN¥- | CN¥435.88 Million | ▼ -1.7 pp |
| 2009 | 31.9% | CN¥128.44 Million | CN¥128.44 Million | CN¥- | CN¥402.25 Million | ▼ -11.3 pp |
| 2008 | 43.2% | CN¥135.80 Million | CN¥135.80 Million | CN¥- | CN¥314.16 Million | ▲ +5.1 pp |
| 2007 | 38.2% | CN¥150.17 Million | CN¥150.17 Million | CN¥- | CN¥393.54 Million | ▼ -25.4 pp |
| 2006 | 63.5% | CN¥156.14 Million | CN¥156.14 Million | CN¥- | CN¥245.77 Million | ▼ -1.6 pp |
| 2005 | 65.1% | CN¥151.59 Million | CN¥151.59 Million | CN¥- | CN¥232.68 Million | ▼ -27.9 pp |
| 2004 | 93.0% | CN¥188.48 Million | CN¥188.48 Million | CN¥- | CN¥202.62 Million | ▼ -14.0 pp |
| 2003 | 107.0% | CN¥202.71 Million | CN¥202.71 Million | CN¥- | CN¥189.49 Million | ▲ +2.1 pp |
| 2002 | 104.9% | CN¥184.99 Million | CN¥184.99 Million | CN¥- | CN¥176.31 Million | ▼ -3.8 pp |
| 2001 | 108.7% | CN¥179.96 Million | CN¥179.96 Million | CN¥- | CN¥165.52 Million | — |